Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides

FEBS Journal

Volumn 276, Issue 8, 2009, Pages 2213-2226

  Béliveau, François ^a   Désilets, Antoine ^a   Leduc, Richard ^a,b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

DESC1; Enzyme kinetics; Hepsin; Internally quenched fluorogenic peptides; Matriptase

Indexed keywords

ALANINE; ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; ARGININE; DESC1 ENZYME; GLUTAMIC ACID; HEPSIN; ISOENZYME; LEUCINE; MATRIPTASE; MATRIPTASE 2; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT ENZYME; SERINE PROTEINASE; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME PURIFICATION; ENZYME SPECIFICITY; FLUORESCENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; SEQUENCE HOMOLOGY;

ANIMALS; CELLS, CULTURED; ESCHERICHIA COLI; FLUORESCENT DYES; HUMANS; KINETICS; MEMBRANE PROTEINS; PEPTIDES; SERINE ENDOPEPTIDASES; SUBSTRATE SPECIFICITY;

EID: 63049086099     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.06950.x     Document Type: Article

References (49)

1. Szabo R Bugge TH (2008) Type II transmembrane serine proteases in development and disease. Int J Biochem Cell Biol 40, 1297 1316.
2. Takeuchi T, Harris JL, Huang W, Yan KW, Coughlin SR Craik CS (2000) Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 275, 26333 26342.
3. Lee SL, Dickson RB Lin CY (2000) Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem 275, 36720 36725.
4. Netzel-Arnett S, Currie BM, Szabo R, Lin CY, Chen LM, Chai KX, Antalis TM, Bugge TH List K (2006) Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation. J Biol Chem 281, 32941 32945.
5. List K, Szabo R, Wertz PW, Segre J, Haudenschild CC, Kim SY Bugge TH (2003) Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. J Cell Biol 163, 901 910.
6. Bhatt AS, Erdjument-Bromage H, Tempst P, Craik CS Moasser MM (2005) Adhesion signaling by a novel mitotic substrate of src kinases. Oncogene 24, 5333 5343.
7. Bhatt AS, Welm A, Farady CJ, Vasquez M, Wilson K Craik CS (2007) Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway. Proc Natl Acad Sci USA 104, 5771 5776.
8. Benaud CM, Oberst M, Dickson RB Lin CY (2002) Deregulated activation of matriptase in breast cancer cells. Clin Exp Metastasis 19, 639 649.
9. List K, Szabo R, Molinolo A, Sriuranpong V, Redeye V, Murdock T, Burke B, Nielsen BS, Gutkind JS Bugge TH (2005) Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev 19, 1934 1950.
10. Avrahami L, Maas S, Pasmanik-Chor M, Rainshtein L, Magal N, Smitt JH, van Marle J, Shohat M Basel-Vanagaite L (2008) Autosomal recessive ichthyosis with hypotrichosis syndrome: further delineation of the phenotype. Clin Genet 74, 47 53.
11. Basel-Vanagaite L, Attia R, Ishida-Yamamoto A, Rainshtein L, Ben Amitai D, Lurie R, Pasmanik-Chor M, Indelman M, Zvulunov A, Saban S et al. (2007) Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14, encoding type II transmembrane serine protease matriptase. Am J Hum Genet 80, 467 477.
12. Desilets A, Beliveau F, Vandal G, McDuff FO, Lavigne P Leduc R (2008) Mutation G827R in matriptase causing autosomal recessive ichthyosis with hypotrichosis yields an inactive protease. J Biol Chem 283, 10535 10542.
13. List K, Currie B, Scharschmidt TC, Szabo R, Shireman J, Molinolo A, Cravatt BF, Segre J Bugge TH (2007) Autosomal ichthyosis with hypotrichosis syndrome displays low matriptase proteolytic activity and is phenocopied in ST14 hypomorphic mice. J Biol Chem 282, 36714 36723.
14. Ramsay AJ, Reid JC, Velasco G, Quigley JP Hooper JD (2008) The type II transmembrane serine protease matriptase-2 - identification, structural features, enzymology, expression pattern and potential roles. Front Biosci 13, 569 579.
15. Velasco G, Cal S, Quesada V, Sanchez LM Lopez-Otin C (2002) Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J Biol Chem 277, 37637 37646.
16. Parr C, Sanders AJ, Davies G, Martin T, Lane J, Mason MD, Mansel RE Jiang WG (2007) Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients. Clin Cancer Res 13, 3568 3576.
17. Sanders AJ, Parr C, Martin TA, Lane J, Mason MD Jiang WG (2008) Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation. J Cell Physiol 216, 780 789.
18. Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, Hartman KR, Mayo MM, Samuel SM, Strouse JJ, Markianos K et al. (2008) Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 40, 569 571.
19. Kazama Y, Hamamoto T, Foster DC Kisiel W (1995) Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J Biol Chem 270, 66 72.
20. Kirchhofer D, Peek M, Lipari MT, Billeci K, Fan B Moran P (2005) Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2. FEBS Lett 579, 1945 1950.
21. Moran P, Li W, Fan B, Vij R, Eigenbrot C Kirchhofer D (2006) Pro-urokinase-type plasminogen activator is a substrate for hepsin. J Biol Chem 281, 30439 30446.
22. Guipponi M, Toh MY, Tan J, Park D, Hanson K, Ballana E, Kwong D, Cannon PZ, Wu Q, Gout A et al. (2008) An integrated genetic and functional analysis of the role of type II transmembrane serine proteases (TMPRSSs) in hearing loss. Hum Mutat 29, 130 141.
23. Klezovitch O, Chevillet J, Mirosevich J, Roberts RL, Matusik RJ Vasioukhin V (2004) Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 6, 185 195.
24. Srikantan V, Valladares M, Rhim JS, Moul JW Srivastava S (2002) HEPSIN inhibits cell growth/invasion in prostate cancer cells. Cancer Res 62, 6812 6816.
25. Kelly KA, Setlur SR, Ross R, Anbazhagan R, Waterman P, Rubin MA Weissleder R (2008) Detection of early prostate cancer using a hepsin-targeted imaging agent. Cancer Res 68, 2286 2291.
26. Viloria CG, Peinado JR, Astudillo A, Garcia-Suarez O, Gonzalez MV, Suarez C Cal S (2007) Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin. Br J Cancer 97, 201 209.
27. Desilets A, Longpre JM, Beaulieu ME Leduc R (2006) Inhibition of human matriptase by eglin c variants. FEBS Lett 580, 2227 2232.
28. Calugaru SV, Swanson R Olson ST (2001) The pH dependence of serpin-proteinase complex dissociation reveals a mechanism of complex stabilization involving inactive and active conformational states of the proteinase which are perturbable by calcium. J Biol Chem 276, 32446 32455.
29. Ito AS, Turchiello RD, Hirata IY, Cezari MH, Meldal M Juliano L (1998) Fluorescent properties of amino acids labeled with ortho-aminobenzoic acid. Biospectroscopy 4, 395 402.
30. Rose T Di Cera E (2002) Substrate recognition drives the evolution of serine proteases. J Biol Chem 277, 19243 19246.
31. Lu D, Yuan X, Zheng X Sadler JE (1997) Bovine proenteropeptidase is activated by trypsin, and the specificity of enteropeptidase depends on the heavy chain. J Biol Chem 272, 31293 31300.
32. Szabo R, Netzel-Arnett S, Hobson JP, Antalis TM Bugge TH (2005) Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity. Biochem J 390, 231 242.
33. Hobson JP, Netzel-Arnett S, Szabo R, Rehault SM, Church FC, Strickland DK, Lawrence DA, Antalis TM Bugge TH (2004) Mouse DESC1 is located within a cluster of seven DESC1-like genes and encodes a type II transmembrane serine protease that forms serpin inhibitory complexes. J Biol Chem 279, 46981 46994.
34. Stennicke HR, Renatus M, Meldal M Salvesen GS (2000) Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8. Biochem J 350, 563 568.
35. Alves MF, Puzer L, Cotrin SS, Juliano MA, Juliano L, Bromme D Carmona AK (2003) S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates. Biochem J 373, 981 986.
36. Ruzza P, Quintieri L, Osler A, Calderan A, Biondi B, Floreani M, Guiotto A Borin G (2006) Fluorescent, internally quenched, peptides for exploring the pH-dependent substrate specificity of cathepsin B. J Peptide Sci 12, 455 461.
37. Cezari MH, Puzer L, Juliano MA, Carmona AK Juliano L (2002) Cathepsin B carboxydipeptidase specificity analysis using internally quenched fluorescent peptides. Biochem J 368, 365 369.
38. Niyomrattanakit P, Yahorava S, Mutule I, Mutulis F, Petrovska R, Prusis P, Katzenmeier G Wikberg JE (2006) Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides. Biochem J 397, 203 211.
39. Harris JL, Backes BJ, Leonetti F, Mahrus S, Ellman JA Craik CS (2000) Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc Natl Acad Sci USA 97, 7754 7759.
40. Herter S, Piper DE, Aaron W, Gabriele T, Cutler G, Cao P, Bhatt AS, Choe Y, Craik CS, Walker N et al. (2005) Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem J 390, 125 136.
41. Shaw SK, Cepek KL, Murphy EA, Russell GJ, Brenner MB Parker CM (1994) Molecular cloning of the human mucosal lymphocyte integrin alpha E subunit. Unusual structure and restricted RNA distribution. J Biol Chem 269, 6016 6025.
42. Schlickum S, Sennefelder H, Friedrich M, Harms G, Lohse MJ, Kilshaw P Schon MP (2008) Integrin alpha E(CD103)beta 7 influences cellular shape and motility in a ligand-dependent fashion. Blood 112, 619 625.
43. Khang I, Sonn S, Park JH, Rhee K, Park D Kim K (2005) Expression of epithin in mouse preimplantation development: its functional role in compaction. Dev Biol 281, 134 144.
44. Hooper JD, Campagnolo L, Goodarzi G, Truong TN, Stuhlmann H Quigley JP (2003) Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues. Biochem J 373, 689 702.
45. Wu Q, Yu D, Post J, Halks-Miller M, Sadler JE Morser J (1998) Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. J Clin Invest 101, 321 326.
46. Yu IS, Chen HJ, Lee YS, Huang PH, Lin SR, Tsai TW Lin SW (2000) Mice deficient in hepsin, a serine protease, exhibit normal embryogenesis and unchanged hepatocyte regeneration ability. Thromb Haemostat 84, 865 870.
47. Betsunoh H, Mukai S, Akiyama Y, Fukushima T, Minamiguchi N, Hasui Y, Osada Y Kataoka H (2007) Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma. Cancer Sci 98, 491 498.
48. Liu Y, Kati W, Chen CM, Tripathi R, Molla A Kohlbrenner W (1999) Use of a fluorescence plate reader for measuring kinetic parameters with inner filter effect correction. Anal Biochem 267, 331 335.
49. Fersht AR (1985) Enzyme Structure and Mechanism. W. H. Freeman, New York, NY.